Predictions This article is also featured on lenNY's Yankees

Toshiba has more than198,000 employees worldwide and annual sales of surpassing U.S. $76 billion(FY2007).For more information on Toshiba's leading innovations, visit thecompany's Web site at http://(C) 2009 Toshiba America Information Systems, Inc. A computer operating system, however, reports storage capacity usingpowers of 2 for the definition of 1 GB 2(30) 1,073,741,824 bytes, andtherefore shows less storage capacity. 6 /PRNewswire-FirstCall/ Atmel(R) Corporation(Nasdaq: ATML) today announced that Steven Laub, Atmel's President and ChiefExecutive Officer, will present at the Eleventh Annual Needham Growth StockConference in New York City on Wednesday, January 7, 2009 at 11:00 a.m.Eastern time.The presentation will be webcast live and archived on the Atmel investorrelations website at http:// .About AtmelAtmel is a worldwide leader in the design and manufacture ofmicrocontrollers, advanced logic, mixed-signal, nonvolatile memory and radiofrequency (RF) components.Leveraging one of the industry's broadestintellectual property (IP) technology portfolios, Atmel provides theelectronics industry with complete system solutions focused on consumer,industrial, security, communications, computing and automotive markets. Contact:Robert Pursel, Director of Investor Relations, 1-408-487-2677SOURCEAtmel CorporationRobert Pursel, Director of Investor Relations of Atmel Corporation,1-408-487-2677. Some hot stove insiders (Ken Rosenthal, Buster Olney, Ken Davidoff and Mark Feinsand) are tweeting away tonight, and all are saying the Yankees are in “active negotiations” for a starting pitcher tonight not named Aaron Harrang.

Rosenthal and Davidoff are calling this a trade, so that could be referring to Mike Puma’s report on dealing with the Cubs. It could even go back as far as the Royals’ interest in Melky Cabrera/Brett Gardner. Olney and Feinsand say it’s a “deal for a starting pitcher.” Who knows if that is opening the door to free agents like Ben Sheets, Justin Duchscherer, etc… UPDATE: Now Jon Heyman is chiming in. I say it’ll be a trade: Cabrera and a couple minor leaguers for Ted Lilly That’s a total guess on my part. Predictions This article is also featured on lenNY's Yankees. Scott Balice Strategies Expands Financial Advisory Services With Opening ofNew York OfficeAddition of Tim Carden and Natasha Holiday Will Grow Firm's East CoastPrivate-Public Partnership EffortsCHICAGO, Jan.

6 /PRNewswire/ Scott Balice Strategies, a woman-owned,full-service financial advisory firm with one of the largest public financeoperations in the Midwest, today announced it has expanded its presence on theeast coast with the official opening of its New York City office.The firmalso appointed two new team members, Managing Director Tim Carden andAssociate Natasha Holiday, to lead its east coast public sector efforts, amarket segment with rising demand for financial advisory services."Scott Balice Strategies currently provides financial advisory andstrategy services to numerous New York area governments, and with the additionof our New York office, we are poised for continued growth," said Lois Scott,President of Scott Balice Strategies."Carden and Holiday will provide theleadership necessary to grow our east coast presence, both in the public andprivate sectors, as they share our tremendous passion for helping makegovernment financially stronger through service, creativity and hard work."Carden joins Scott Balice Strategies with more than 30 years of experiencein the public finance field.After serving as Commissioner of Human Services,New Jersey's largest agency, and as Cabinet Secretary to the Governor, hespent 10 years as a public finance investment banker, specializing intransportation, infrastructure and general government finance.Since 1995,Carden has been a partner with the Public Private Strategy Group, a consultingfirm dedicated to expanding the capacity of government services throughpublic-private partnerships (P3) around the country.He has remained activein civic and governmental affairs throughout his career and currently serveson the board of the New Jersey Economic Development Authority, where he chairsthe Audit and Finance committee.Carden also serves on the boards of the NewJersey Conservation Foundation and the Association for Children of New Jersey."The needs of state and local governments are far greater than theresources available to meet them," said Carden."Scott Balice has theanalytic resources, the intellect and the work ethic to help address thoseneeds.Private sector appetite for investing in public enterprise is growing.Our goal is to increase government's capacity to finance and buildinfrastructure by creating strategic partnerships that protect the publicinterest while providing opportunity for investment and innovation."Holiday joins Scott Balice Strategies from the Public Sector andInfrastructure Group at Goldman Sachs, where she was involved with financingnumerous transportation and infrastructure projects.Prior to that, sheserved on economic development and revitalization projects and has previouslyheld positions at Centre City Development Corporation and the City of New Yorkas an Urban Fellow.Scott Balice Strategies, based in Chicago, has a portfolio of businessthat includes public and private projects in 14 states and on threecontinents, spanning a wide range of projects.Since it inception six yearsago, the firm has advised more than 200 assignments, representing projectswith total value topping $35 billion.For more information about Scott BaliceStrategies, please visit http:// Scott Balice StrategiesScott Balice Strategies, founded in 2003, is a woman-owned firm formed toprovide best in class financial advisory and strategy services. SKOKIE, Ill., Jan. 6 /PRNewswire/ Horizon Therapeutics, Inc., aprivately held biopharmaceutical company, today announced the appointment ofAmy Grahn to vice president, clinical operations and Iain Duncan to seniorvice president of operations."Amy and Iain bring valuable operations experience that is vital as weprepare regulatory filings in the U.S. "During theirrespective careers, Amy and Iain have been instrumental in the growth ofstart-up as well as established biotech and pharmaceutical companies and theirleadership will be an important part of Horizon's future growth."Ms. Grahn has more than 20 years pharmaceutical industry experiencespanning pre-clinical research to sales, with a primary focus on clinicaloperations.Ms. Grahn was most recently vice president of clinical operationsat MedGenesis Therapeutix Inc.